bupivacaine hydrochloride

FDA Drug Profile — bupivacaine hydrochloride, Marcaine, Bupivacaine Hydrochloride, Sensorcaine MPF, BUPIVACAINE HYDROCHLORIDE

bupivacaine hydrochloride is listed in the FDA National Drug Code directory with 18 NDC codes, marketed under brand names including bupivacaine hydrochloride, Marcaine, Bupivacaine Hydrochloride. Available dosage form: injection, solution.

Drug details

Generic Name
bupivacaine hydrochloride
Brand Names
bupivacaine hydrochloride, Marcaine, Bupivacaine Hydrochloride, Sensorcaine MPF, BUPIVACAINE HYDROCHLORIDE
Application Number
ANDA216040
Sponsor
Meitheal Pharmaceuticals Inc
NDC Codes
18
Dosage Forms
INJECTION, SOLUTION
Routes
EPIDURAL, RETROBULBAR, INFILTRATION, INTRACAUDAL, PERINEURAL
Active Ingredients
BUPIVACAINE HYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE Bupivacaine hydrochloride injection is indicated in adults for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. Specific concentrations and presentations of bupivacaine hydrochloride injection is recommended for each type of block indicated to produce local or regional anesthesia or analgesia [see Dosage and Administration (2.2) ]. Limitations of Use Not all blocks are indicated for use with bupivacaine hydrochloride injection given clinically significant risks associated with use [see Dosage and Administration (2.2) , Contraindications (4) , Warnings and Precautions (5.1 , 5.5 , 5.7 , 5.9 )]. Bupivacaine hydrochloride injection contains bupivacaine, an amide local anesthetic is indicated in adults for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. For each type of block indicated to produce local or regional anesthesia or analgesia, specific concentrations and presentations are recommended. ( 1 , 2.2 ) Limitations of Use Not all blocks are indicated for use with bupivacaine hydrochloride injection given clinically significant risks associated with use. ( 1 , 2.2 , 4 , 5.1 , 5.5 , 5.7 , 5.9 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.